Michael Altman and Konstantin Poukalov Resign From Lyra Therapeutics Board

Dow JonesDec 13 17:28 ET

Lyra Health Welcomes Jennifer Schulz as Chief Executive Officer

BusinesswireDec 5 10:05 ET

Incendia Therapeutics Appoints Bradford Smith as Chief Financial Officer

BusinesswireDec 3 08:00 ET

Lyra Therapeutics: Hold Rating Due to Uncertainty in ENLIGHTEN-2 Trial Outcomes

TipRanksNov 14 06:16 ET · Ratings

Express News | Lyra Therapeutics Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 Sales Results

BenzingaNov 13 11:04 ET

BTIG Maintains Lyra Therapeutics(LYRA.US) With Hold Rating

Moomoo NewsNov 13 06:36 ET · Ratings